MapLight Therapeutics, Inc. (MPLT)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
37. 87
+0.65
+1.7464%
$
29.89M Market Cap
- P/E Ratio
- Div Yield
778,800 Volume
- Eps
$ 37.22
Previous Close 
Want to track MPLT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MapLight Therapeutics, Inc. (MPLT) Discusses Top Line Phase II IRIS Study Results for ML-004 in Autism Spectrum Disorder Transcript
MapLight Therapeutics, Inc. (MPLT) Discusses Top Line Phase II IRIS Study Results for ML-004 in Autism Spectrum Disorder Transcript
Seekingalpha | 3 weeks ago
